| scholarly article | Q13442814 |
| P819 | ADS bibcode | 1990PNAS...87.7762B |
| P356 | DOI | 10.1073/PNAS.87.19.7762 |
| P932 | PMC publication ID | 54828 |
| P698 | PubMed publication ID | 2217208 |
| P5875 | ResearchGate publication ID | 20939268 |
| P2093 | author name string | W H Lee | |
| R Bookstein | |||
| W E Grizzle | |||
| F Hong | |||
| S A Madreperla | |||
| P Rio | |||
| C Allred | |||
| P2860 | cites work | Expression of ras oncogene p21 in prostate cancer | Q44354411 |
| Differential phosphorylation of c-Abl in cell cycle determined by cdc2 kinase and phosphatase activity. | Q46008782 | ||
| Suppression of tumorigenicity of human prostate carcinoma cells by replacing a mutated RB gene. | Q46016044 | ||
| Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation | Q46219366 | ||
| Antibodies detecting abnormalities of the retinoblastoma susceptibility gene product (pp110RB) in osteosarcomas and synovial sarcomas | Q46228936 | ||
| Human retinoblastoma susceptibility gene: cloning, identification, and sequence | Q48348004 | ||
| Multistage carcinogenesis induced by ras and myc oncogenes in a reconstituted organ | Q53516187 | ||
| Chromosome study of five cancers of the prostate | Q54253017 | ||
| Expression of the c-myc protooncogene in human prostatic carcinoma and benign prostatic hyperplasia | Q68952062 | ||
| The retinoblastoma susceptibility gene encodes a nuclear phosphoprotein associated with DNA binding activity | Q24299515 | ||
| Two distinct and frequently mutated regions of retinoblastoma protein are required for binding to SV40 T antigen | Q24337366 | ||
| Mutation and cancer: statistical study of retinoblastoma | Q24618185 | ||
| Purification, biochemical characterization, and biological function of human esterase D | Q24629865 | ||
| SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene | Q28281071 | ||
| Structure of the human retinoblastoma gene | Q34291500 | ||
| Structure and expression of the murine retinoblastoma gene and characterization of its encoded protein | Q34299480 | ||
| The retinoblastoma gene is frequently altered leading to loss of expression in primary breast tumours. | Q34666629 | ||
| Detection of DNA sequence polymorphisms by enzymatic amplification and direct genomic sequencing | Q35197586 | ||
| JC papovavirus large tumor (T)-antigen expression in brain tissue of acquired immune deficiency syndrome (AIDS) and non-AIDS patients with progressive multifocal leukoencephalopathy | Q35598327 | ||
| C-terminal truncation of the retinoblastoma gene product leads to functional inactivation | Q37654636 | ||
| Frequent inactivation of the retinoblastoma anti-oncogene is restricted to a subset of human tumor cells | Q37734603 | ||
| The molecular genetics of hemoglobin | Q38686522 | ||
| The molecular genetics of cancer | Q39753201 | ||
| PCR-based detection of a polymorphic BamHI site in intron 1 of the human retinoblastoma (RB) gene | Q40515474 | ||
| Suppression of the neoplastic phenotype by replacement of the RB gene in human cancer cells | Q41407134 | ||
| Deletion of a splice donor site ablates expression of the following exon and produces an unphosphorylated RB protein unable to bind SV40 T antigen | Q41756693 | ||
| Activated Ki-ras oncogene in human prostatic adenocarcinoma | Q42809362 | ||
| Cancer statistics, 1990. | Q43526438 | ||
| Oncogenic point mutations in the human retinoblastoma gene: their application to genetic counseling | Q43622286 | ||
| Neuroendocrine differentiation in prostatic carcinomas. A retrospective autopsy study | Q43900936 | ||
| P433 | issue | 19 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | retinoblastoma | Q500695 |
| P304 | page(s) | 7762-7766 | |
| P577 | publication date | 1990-10-01 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Promoter deletion and loss of retinoblastoma gene expression in human prostate carcinoma | |
| P478 | volume | 87 |
| Q28539588 | A TRIP230-retinoblastoma protein complex regulates hypoxia-inducible factor-1α-mediated transcription and cancer cell invasion |
| Q35835242 | AGE/RAGE/Akt pathway contributes to prostate cancer cell proliferation by promoting Rb phosphorylation and degradation |
| Q40958157 | Abnormalities of retinoblastoma gene expression in hematological malignancies |
| Q41231236 | Alterations of the retinoblastoma gene in human prostate adenocarcinoma |
| Q40888865 | An in vitro system to characterize prostate cancer progression identified signaling required for self-renewal |
| Q47773124 | Analysis of retinoblastoma gene expression in human prostate tissue |
| Q40762889 | Androgen stimulated cellular proliferation in the human prostate cancer cell line LNCaP is associated with reduced retinoblastoma protein expression |
| Q35190865 | Animal models for the study of prostate carcinogenesis |
| Q36748190 | Antibodies specific for the human retinoblastoma protein identify a family of related polypeptides |
| Q72067102 | Association of transforming growth factor-β1 with prostate cancer: An immunohistochemical study |
| Q37745567 | Bidirectional transcription of Linc00441 and RB1 via H3K27 modification-dependent way promotes hepatocellular carcinoma |
| Q40782148 | Cell cycle checkpoint efficiency and cellular response to paclitaxel in prostate cancer cells |
| Q33890627 | Chemoprevention of Bladder and Prostate Carcinoma |
| Q41478688 | Chromosome 13 transfer provides evidence for regulation of RB1 protein expression |
| Q36793471 | Cooperativity of imprinted genes inactivated by acquired chromosome 20q deletions |
| Q38302408 | CpG island methylation status and mutation analysis of the RB1 gene essential promoter region and protein-binding pocket domain in nervous system tumours |
| Q41046879 | Cyclin D1 expression in human prostate carcinoma cell lines and primary tumors |
| Q37281675 | Cytokine genetic polymorphisms and prostate cancer aggressiveness |
| Q45613582 | Detection and expression of human BK virus sequences in neoplastic prostate tissues |
| Q38316674 | Detection of sex‐region Y (SRY) transcripts in human prostate adenocarcinoma and benign prostatic hypertrophy |
| Q35833088 | Detection of the apoptosis-suppressing oncoprotein bc1-2 in hormone-refractory human prostate cancers. |
| Q52237401 | Differences in patterns of allelic loss between two common types of adult cancer, breast and colon carcinoma, and Wilms' tumor of childhood |
| Q71646676 | Differential expression of transforming growth factor-?1 and ?3 as well as C-FOS mRNA in normal human prostate, benign prostatic hyperplasia and prostatic cancer |
| Q40572625 | Differential regulation of apoptotic genes by Rb in human versus mouse cells |
| Q41036706 | E1A Transformed Normal Human Prostate Epithelial Cells Contain a 16q Deletion |
| Q29619196 | Effects of an Rb mutation in the mouse |
| Q33867671 | Expression of altered retinoblastoma protein inversely correlates with tumor invasion in gastric carcinoma. |
| Q55327249 | Expression of nm23‐Hl and nm23‐H2 Proteins in Prostate Carcinoma |
| Q72169629 | Expression of p53 protein in prostate cancers of different histologic types |
| Q71960044 | Expression of retinoblastoma gene (Rb) protein in T12MO prostatic adenocarcinoma |
| Q37636172 | Extensive contribution of Rb-deficient cells to adult chimeric mice with limited histopathological consequences |
| Q35585887 | Eye cancer: unique insights into oncogenesis: the Cogan Lecture |
| Q41409355 | Familial prostate cancer: the evidence and the Cancer Research Campaign/British Prostate Group (CRC/BPG) UK Familial Prostate Cancer Study |
| Q73503573 | G(1)/S cell cycle proteins as markers of aggressive prostate carcinoma |
| Q41659418 | Genes involved in oncogenesis |
| Q73709115 | Genetic alterations in incidentally diagnosed, transitional zone prostate cancer: a seven year follow-up |
| Q40553433 | Genetic alterations in prostate adenocarcinoma. |
| Q41035988 | Genetic basis and clonal evolution of human prostate cancer |
| Q73978688 | Genetic changes in prostate cancer |
| Q40835798 | Genetics of cancer predisposition and progression |
| Q36216850 | Genetics of primary intraocular tumors |
| Q40363836 | Genome-wide two-locus interaction analysis identifies multiple epistatic SNP pairs that confer risk of prostate cancer: A cross-population study. |
| Q34293483 | HTLV-I Tax related dysfunction of cell cycle regulators and oncogenesis of adult T cell leukemia |
| Q35032556 | Hormone-refractory prostate cancer: a multi-step and multi-event process |
| Q39079539 | Id4 promotes senescence and sensitivity to doxorubicin-induced apoptosis in DU145 prostate cancer cells |
| Q48099795 | Identification of a gene on human chromosome 8q11 that is differentially expressed during prostate-cancer progression |
| Q73952737 | Identification of genetic markers for prostatic cancer progression |
| Q41655149 | Image analysis quantitation of immunoreactive retinoblastoma protein in human thyroid neoplasms with a streptavidin-biotin-peroxidase staining technique |
| Q40943389 | Immortalization of human prostate epithelial cells by HPV 16 E6/E7 open reading frames |
| Q35806390 | In vitro and in vivo model systems used in prostate cancer research |
| Q46120492 | IncreasedRB1 abnormalities in human primary prostate cancer following combined androgen blockade |
| Q42281248 | Infrequent involvement of p53 gene mutations in the tumourigenesis of Japanese prostate cancer |
| Q38289940 | Inhibitor of differentiation 4 (ID4): From development to cancer |
| Q37167727 | Insights from mouse models into human retinoblastoma |
| Q43249619 | Is PTEN loss associated with clinical outcome measures in human prostate cancer? |
| Q73283461 | Limiting the location of a putative human prostate cancer tumor suppressor gene at chromosome 13q14.3. |
| Q34719607 | Loss of the retinoblastoma susceptibility gene (RB1) is a frequent and early event in prostatic tumorigenesis. |
| Q77780761 | Low frequency of oncogenic mutations in the core promoter region of the RB1 gene |
| Q24562051 | Mendelian inheritance of familial prostate cancer |
| Q35217386 | Models of metastatic prostate cancer: a transgenic perspective |
| Q68330915 | Molecular Definition of Interstitial Deletions of Chromosome 13 in Leukemic Cells |
| Q74736163 | Molecular Genetics of Renal Cell Carcinoma |
| Q77143141 | Molecular analysis of the retinoblastoma (RB1) gene in acute myeloid leukemia patients |
| Q71766929 | Molecular biology of prostate cancer |
| Q76402656 | Molecular biology of prostate cancer |
| Q41591490 | Molecular cloning of cellular genes encoding retinoblastoma-associated proteins: identification of a gene with properties of the transcription factor E2F |
| Q58136321 | Molecular genetics of prostate cancer |
| Q37827625 | Molecular insights into altered cell cycle regulation and genitourinary malignancy |
| Q24672410 | Molecular pathology of prostate cancer |
| Q40410709 | Murine models of neoplasia: functional analysis of the tumour suppressor genes Rb-1 and p53. |
| Q38920403 | NUSAP1 expression is upregulated by loss of RB1 in prostate cancer cells |
| Q42244850 | NUSAP1 promotes invasion and metastasis of prostate cancer |
| Q41605880 | No alterations in exon 21 of the RB1 gene in sarcomas and carcinomas of the breast, colon, and lung |
| Q40943398 | Novel 20-epi-vitamin D3 analog combined with 9-cis-retinoic acid markedly inhibits colony growth of prostate cancer cells |
| Q40842954 | Novel amplification unit at chromosome 3q25-q27 in human prostate cancer |
| Q42451874 | Novel nuclear phosphoprotein pp32 is highly expressed in intermediate- and high-grade prostate cancer |
| Q41665743 | Oncogenic germ-line mutations in Sp1 and ATF sites in the human retinoblastoma gene |
| Q30333986 | Oncogenic point mutations in exon 20 of the RB1 gene in families showing incomplete penetrance and mild expression of the retinoblastoma phenotype |
| Q28292541 | PTEN and GSK3beta: key regulators of progression to androgen-independent prostate cancer |
| Q34444393 | Prostate cancer in a transgenic mouse |
| Q37150080 | Prostate cancer old problems and new approaches : Part I. epidemiology, incidence and genetic alterations |
| Q73447336 | RB protein expression in human endometrial carcinomas--an immunohistochemical study |
| Q40456228 | Recent advances in the molecular genetics of urogenital tumors |
| Q34138129 | Recessive oncogenes: current status |
| Q38481899 | Reduced expression of retinoblastoma (Rb) gene protein is related to cell proliferation and prognosis in transitional-cell bladder cancer |
| Q37756926 | Regulation of NF-E2-related factor 2 signaling for cancer chemoprevention: antioxidant coupled with antiinflammatory |
| Q33725507 | Regulation of RB transcription in vivo by RB family members |
| Q47905083 | Retinoblastoma Protein Expression in Ovarian Epithelial Neoplasms |
| Q46247217 | Retinoblastoma and p53 protein expression in sporadic colorectal cancers |
| Q42807149 | Retinoblastoma cell lines Y79, RB355 and WERI-Rb27 are genetically related |
| Q73821364 | Retinoblastoma expression in thyroid neoplasms |
| Q40638710 | Retinoblastoma gene expression in human non-melanoma skin cancer |
| Q34725035 | Retinoblastoma gene structure and product expression in human gastric carcinomas |
| Q40110301 | Retinoblastoma tumor suppressor status is a critical determinant of therapeutic response in prostate cancer cells |
| Q74738676 | Sensitivity of human prostatic carcinoma cell lines to low dose rate radiation exposure |
| Q41526922 | Strategies for Approaching Retinoblastoma Tumor Suppressor Gene Therapy |
| Q48710025 | Structural and developmental analysis of the mouse peripherin/rds gene |
| Q71785376 | Structural integrity of the cyclin‐dependent kinase inhibitor genes, p15, p16 and p18 in myeloid leukaemias |
| Q80212337 | Suppressive effects of antiandrogens, finasteride and flutamide on development of prostatic lesions in a transgenic rat model |
| Q57492228 | Targeted nonviral gene therapy in prostate cancer |
| Q57113379 | The Genomics of Prostate Cancer: A Historic Perspective |
| Q48317607 | The Genomics of Prostate Cancer: emerging understanding with technologic advances |
| Q41604509 | The aetiology and pathogenesis of prostate cancer |
| Q33610876 | The cellular and molecular basis of prostate cancer |
| Q34771729 | The loss of TGF-beta signaling promotes prostate cancer metastasis |
| Q35367235 | The polymerase chain reaction: its use in the molecular characterization and diagnosis of cancers |
| Q38306731 | The retinoblastoma gene product RB stimulates Sp1-mediated transcription by liberating Sp1 from a negative regulator |
| Q36962414 | The retinoblastoma protein physically associates with the human cdc2 kinase |
| Q36643356 | The transcription factor E2F-1 mediates the autoregulation of RB gene expression |
| Q37560404 | Thermally targeted p21 peptide enhances bortezomib cytotoxicity in androgen-independent prostate cancer cell lines |
| Q37188430 | Thrombin induces tumor cell cycle activation and spontaneous growth by down-regulation of p27Kip1, in association with the up-regulation of Skp2 and MiR-222 |
| Q37910715 | Time to stratify? The retinoblastoma protein in castrate-resistant prostate cancer |
| Q28509125 | Tissue-specific tumor suppressor activity of retinoblastoma gene homologs p107 and p130 |
| Q40954124 | Total androgen blockade for prostate cancer: the end does not justify the means |
| Q35190856 | Transforming growth factor β1 as a biomarker for prostate cancer |
| Q67556469 | Tumor suppressor genes |
| Q30499489 | Tumor-suppressor genes: cardinal factors in inherited predisposition to human cancers |
| Q41409406 | Tumour-suppressor genes in prostatic oncogenesis: a positional approach |
| Q34718099 | Visualizing dynamic E2F-mediated repression in vivo |
| Q34305880 | ZFY gene expression and retention in human prostate adenocarcinoma |
| Q34099399 | pRB expression in esophageal mucosa of individuals at high risk for squamous cell carcinoma of the esophagus |
| Q34768305 | pRb-Independent growth arrest and transcriptional regulation of E2F target genes |
| Q40766756 | pRb-expressing adenovirus Ad5-Rb attenuates the p53-induced apoptosis in cervical cancer cell lines. |
Search more.